BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17126747)

  • 1. Chemopreventative thoughts for photodynamic therapy.
    Bissonnette R
    Dermatol Clin; 2007 Jan; 25(1):95-100. PubMed ID: 17126747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy for actinic keratoses.
    Kalisiak MS; Rao J
    Dermatol Clin; 2007 Jan; 25(1):15-23. PubMed ID: 17126738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients.
    Dragieva G; Prinz BM; Hafner J; Dummer R; Burg G; Binswanger U; Kempf W
    Br J Dermatol; 2004 Jul; 151(1):196-200. PubMed ID: 15270891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reader's letter concerning K. Kreutzer, B.Bonnekoh, I. Franke, H. Gollnick. Photodynamic therapy with methylaminooxopentanoate (Metvix) and a broad band light source (Photdyn 501): practical experiences in problem patients with actinic keratoses and basal cell carcinomas. JDDG 2004,12:992-999].
    Breuninger H
    J Dtsch Dermatol Ges; 2005 May; 3(5):397. PubMed ID: 16372809
    [No Abstract]   [Full Text] [Related]  

  • 5. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma.
    Szeimies RM
    Dermatol Clin; 2007 Jan; 25(1):89-94. PubMed ID: 17126746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with topical methyl- and hexylaminolevulinate for prophylaxis and treatment of UV-induced SCC in hairless mice.
    Togsverd-Bo K; Lerche CM; Poulsen T; Wulf HC; Haedersdal M
    Exp Dermatol; 2010 Aug; 19(8):e166-72. PubMed ID: 20100196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminolevulinic acid and photodynamic combination therapy in the treatment of actinic keratoses: caring for the patient.
    Harvie SE
    Dermatol Nurs; 2007 Feb; 19(1):31-4, 39. PubMed ID: 17330552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients.
    Wulf HC; Pavel S; Stender I; Bakker-Wensveen CA
    Acta Derm Venereol; 2006; 86(1):25-8. PubMed ID: 16585985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
    Itkin A; Gilchrest BA
    Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Hotline: Facial skin rejuvenation in a patient treated with photodynamic therapy for actinic keratosis.
    Bruscino N; Rossi R; Dindelli M; Ghersetich I; Lotti T
    Dermatol Ther; 2010; 23(1):86-9. PubMed ID: 20136912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
    Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
    Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
    Morton CA
    Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: photodynamic therapy with methyl aminolevulinate induces phototoxic reactions on areas of the nose adjacent to basal cell carcinomas and actinic keratoses.
    Toll A; Parera ME; Vélez M; Pujol RM
    Dermatol Surg; 2008 Aug; 34(8):1145-7; discussion 1147-8. PubMed ID: 18518890
    [No Abstract]   [Full Text] [Related]  

  • 14. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study.
    Szeimies RM; Karrer S; Radakovic-Fijan S; Tanew A; Calzavara-Pinton PG; Zane C; Sidoroff A; Hempel M; Ulrich J; Proebstle T; Meffert H; Mulder M; Salomon D; Dittmar HC; Bauer JW; Kernland K; Braathen L
    J Am Acad Dermatol; 2002 Aug; 47(2):258-62. PubMed ID: 12140473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malassezia growth on peritumoral skin after routine methyl-5-aminolevulinate photodynamic therapy for actinic keratosis and nonmelanoma skin cancer.
    Gilaberte Y; Aspiroz C; Alejandre C; Rezusta A
    Actas Dermosifiliogr; 2015; 106(1):70-1. PubMed ID: 25089033
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies of methyl aminolevulinate photodynamic therapy for actinic keratosis].
    Fernández-Guarino M; Harto A; Jaén P
    Actas Dermosifiliogr; 2010 May; 101(4):315-22. PubMed ID: 20487686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Squamous cell carcinoma following photodynamic therapy].
    Schmutz JL
    Ann Dermatol Venereol; 2015; 142(6-7):463-4. PubMed ID: 25863920
    [No Abstract]   [Full Text] [Related]  

  • 18. Current treatments of actinic keratosis.
    Gold MH; Nestor MS
    J Drugs Dermatol; 2006 Feb; 5(2 Suppl):17-25. PubMed ID: 16485877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate.
    Angell-Petersen E; Sørensen R; Warloe T; Soler AM; Moan J; Peng Q; Giercksky KE
    J Invest Dermatol; 2006 Feb; 126(2):265-71. PubMed ID: 16374471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple large-surface photodynamic therapy sessions with topical or systemic aminolevulinic acid and blue light in UV-exposed hairless mice.
    Liu Y; Viau G; Bissonnette R
    J Cutan Med Surg; 2004; 8(2):131-9. PubMed ID: 15685390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.